• LAST PRICE
    0.0105
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0070/ 100
  • Ask / Lots
    0.0140/ 269
  • Open / Previous Close
    0.0000 / 0.0105
  • Day Range
    ---
  • 52 Week Range
    Low 0.0070
    High 0.0679
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.0105
TimeVolumeLTUS
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLTUS
Lotus Pharmaceuticals Inc
20.6M
0.2x
+42.39%
United StatesTXMD
TherapeuticsMD Inc
65.7M
-1.8x
---
United StatesUPC
Universe Pharmaceuticals Inc
12.4M
2.5x
---
United StatesCPIX
Cumberland Pharmaceuticals Inc
37.7M
-4.1x
---
United StatesELTP
Elite Pharmaceuticals Inc
34.4M
5.0x
-21.24%
United StatesSHWZ
Medicine Man Technologies Inc
57.2M
-3.2x
---
As of 2022-09-28

Company Information

Lotus Pharmaceuticals, Inc. (Lotus) develops, manufactures, and sells pharmaceuticals in the China. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. Its drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. It operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. (Liang Fang) and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd. (En Zhe Jia), collectively Lotus East. Lotus East is engaged in the production, trade and retailing of pharmaceuticals, focusing on the development of medicines and investing in strategic growth to address various medical needs. Lotus East owns and operates 10 drug stores throughout Beijing, China that sell Western and traditional Chinese medications, and generate revenues from the leasing of retail space to third party vendors in its retail stores.

Contact Information

Headquarters
16 Cheng Zhuang Road, Feng Tai DistrictBEIJING, BEJ, China 100071
Phone
106-389-9868
Fax
106-389-9867

Executives

Chairman of the Board, President, Chief Executive Officer
Zhongyi Liu
Chief Financial Officer
Yan Zeng
Vice President - Corporate Development
Xing Shen
Director
Lu Jun
Independent Director
Fan Lijun

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$20.6M
Revenue (TTM)
$70.8M
Shares Outstanding
2.9B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.80
EPS
$0.06
Book Value
$3.33
P/E Ratio
0.2x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
5.3x
Operating Margin
1.14%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.